Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126695251 | 12669525 | 1 | I | 20160806 | 20160819 | 20160819 | EXP | US-CONCORDIA PHARMACEUTICALS INC.-CO-KX-US-2016-020 | CONCORDIA | 50.00 | YR | F | Y | 0.00000 | 20160819 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126695251 | 12669525 | 1 | PS | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | Oral | Y | 0 | 15 | MG | ||||||||
126695251 | 12669525 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | U | 0 | |||||||||||
126695251 | 12669525 | 3 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126695251 | 12669525 | 1 | Hyperkalaemia |
126695251 | 12669525 | 2 | Immunosuppression |
126695251 | 12669525 | 3 | Immunosuppression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126695251 | 12669525 | HO |
126695251 | 12669525 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126695251 | 12669525 | Abdominal pain | |
126695251 | 12669525 | Abdominal tenderness | |
126695251 | 12669525 | Acute kidney injury | |
126695251 | 12669525 | Gastrointestinal necrosis | |
126695251 | 12669525 | Hypovolaemia | |
126695251 | 12669525 | Large intestine perforation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |